LC-(TOF) MS Analysis of Benzodiazepines in Urine from Alleged Victims of Drug-Facilitated Sexual Assault
Journal of Analytical Toxicology, Vol. 31, October 2007
LC-(TOF) MS Analysisof Benzodiazepinesin Urine
from Alleged Victims of Drug-Facilitated Sexual Assault
Mahmoud A. EISohly 1,2,3,*, Waseem Gul 1,2, Timothy P. Murphy 1, Bharathi Avula 2, and Ikhlas A. Khan 2,4
I Abstract
I
The presentstudy employs a recently reported liquid
chromatography(time of flight) massspectrometry procedure
for the simultaneousanalysis of 22 benzodiazepines in
human urine specimens. The analysisfocused on the most
commonly prescribed benzodiazepines and/or their metabolites.
Using this method, the limit of quantitation for the
benzodiazepines tested ranged from 2 to 10 ng/mL, while
the limit of detection range was 0.5 to 3.0 ng/mL. Urine
specimenscollected from alleged victims of drug-facilltated
sexual assault (156 specimens) were tested. Only 19 out of
the 22 benzodiazepinesanalyzed were detected in these
specimens.These samespecimens were previously screened
for benzodiazepines by various immunoassaytechniques
using a 50 ng/mL cut-off level and confirmed by a gas
chromatography--massspectrometry method after acid
hydrolysisto their benzophenone skeletons,thus making the
identification of the specific benzodiazepine(s) involved
impossible for most specimens. This study aims to offer an
alternative methodology that would allow such identification
for similar specimens.Additionally, the distribution of the
individual benzodiazepines of interest among the 156
specimensas well as their prevalence in specimensoriginating
in different U.S. statesis presented.
Introduction
last few years to the area of drug-facilitated sexual assault.
One of the benzodiazepines that is most often implicated in
drug-facilitated sexual assault cases is flunitrazepam (3,4), a
drug that has been marketed for over 20 years for the treatment of severe sleep disorders.
In the late 1990s, F. Hoffrnan-LaRoche (Roche), the
manufacturer of flunitrazepam (brand name Rohypnol),
embarked on a program to determine the use of drugs, including flunitrazeparn, in alleged cases of sexual assault,
by sponsoring the development of a sensitive method [gas
chromatography-mass spectrometry (GC-MS)] to detect
flunitrazepam rnetabolite in urine at a level below 1 ng/mL
(5) and by initiating and offering a testing program of independent urine analyses to victims of alleged sexual assault
in the United States. The program included testing for a
wide range of drugs of abuse including alcohol. A total of
3303 urine specimens were submitted and tested under this
program, and the results of the testing have been previously
reported (6). Although the testing showed only a few urine
specimens to be positive for flunitrazepam (9 specimens), over
300 specimens were positive for the benzodiazepines class
with a high percentage of specimens testing positive for more
than one drug, indicating exposure to polypharmacy. The
GC-MS method used in that study involved acid hydrolysis
of the benzodiazepines to their benzophenone skeleton in
order to increase the sensitivity (5), thus making impossible
the determination of the benzodiazepine(s) involved in many
cases.
Benzodiazepines comprise a class of clinically important
drugs with therapeutic activities covering a wide range of indications thus rendering them useful as tranquilizers, anticonvulsants, muscle relaxants, and sleep aids (1). The
pharmacological properties of benzodiazepines, as valuable as
they are in clinical practice, are cause for serious abuse problems all over the world (2). Such abuse has extended over the
* Author to whom correspondenceshould be addressed.
In a previous publication (7), the authors of the present
study presented a newly developed procedure for the simultaneous analysis of 22 different benzodiazepines using liquid
chromatography coupled with (time-of-flight) mass spectrometry, LC-(TOF) MS. The sensitivity of the new LC-(TOF)
MS procedure was such that the limit of detection ranged
from 0.5 to 3.0 ng/mL for all benzodiazepinestested. For those
benzodiazepines where the SOFT DFSA Committee has recommended a maximum detection limit, the detection limit of
this procedure is 5-10 times lower, except for 7-aminofluni-
Reproduction Iphotocopying) of editorial content of this journal is pn~hibited without publisher's permission.
505
IEISohlyLaboratories, Incorporated, 5 Industrial Park Drive, Oxford, Mississippi38655; 2National Center for
Natural Products Research(NCNPR),School of Pharmacy, University of Mississippi, University, Mississippi38677;
3Department of Pharmaceutics,School of Pharmacy, University of Mississippi, University, Mississippi38677; and
4Department of Pharmacognosy,School of Pharrnacy, University of Mississippi, University, Mississippi38677
Journal of Analytical Toxicology, Vol. 31, October 2007
trazepam, where this procedure's LOD is only 2.5 times lower.
The method was used to re-analyze 13 specimens that screened
positive by the immunoassay used in the study mentioned but
were not confirmed by the existing GC-MS method. All 13
specimens were confirmed for one or more benzodiazepines
using the LC-(TOF) MS method.
The present study describes the use of the LC-(TOF) MS
procedure for the analysis of 156 specimens collected nationwide from alleged victims of drug-facilitated sexual assault in
an attempt to ascertain the involvement of benzodiazepines in
these cases as well as the regional distribution of individual
benzodiazepines within the 35 U.S. states included in this
study.
Materials
Standard solutions
7-Aminonorflunitrazepam,7-acetamido-norflunitrazepam,
bromazepam, 3-OH-flunitrazepam, 2-OH-flurazepam,
diazepam, 7-aminoclonazepam,desmethylflunitrazepam, lorazepam, norfludiazepam, flunitrazepam, 7-aminoflunitrazepam, a-OH-alprazolam-ds,flunitrazepam-dT,temazepam,
iormetazepam, triazolam, nitrazepam, a-OH-triazolam, nordiazepam, midazolam,and alprazolamwere purchased from
Cerilliant (RoundRock,"IX).Oxazepam,a-hydroxyalprazolam,
oxazepam-ds, and nordiazepam-d5 were purchased from
Sigma, and 7-aminoflunitrazepam-d3 was obtained from
Total # of
State Specimens 1'
AK
AL
AR
CA
CO
CT
DE
FL
HI
IL
IN
LA
MA
MD
MI
MN
MO
NC
NE
NH
NJ
NM
NV
NY
OH
OK
OR
PA
SC
TN
TX
UT
VA
WA
WI
WV
Total
%
2
4
2
19
3
1
1
7
5
5
8
1
4
5
7
3
1
4
2
1
2
3
4
I
2
I
7
I
2
2
8
I
2
I
7
I
2
2
8
1
1
5
3
1
1
5
3
1
1
5
2
1
1
2
2
2
I
1
1
2
2
2
I
2
1
1
1
2
I
1
1
5
3
1
2
1
2
2
2
I
1
1
1
1
1
1
4
2
2
2
2
2
4
3
2
6
3
7
38
4
2
4
1
1
156
1
1
1
2
5
I
6
7
8
2
2
I
I
2
I
2
2
I
3
2
2
2
2
3
2
5
5
1
1
2
2
1
1
1
1
2
1
1
2
2
2
1
1
1
4
2
6
11
2
1
2
1
1
1
2
1
1
5
2
6
15
2
1
2
1
1
1
2
1
1
5
1
6
12
1
1
2
1
1
1
2
1
1
5
2
6
17
1
1
2
1
67
43.1
1
75
48.1
1
1
63
78
40.4 50.0
9
10
11
12
13
14
15
16
17
2
18
19
1
1
I
2
1
2
1
1
1
2
1
1
3
1.92
1
1
1
2
I
7
1
1
1
1
2
I
7
1
1
1
9
5
2
1
35
22.4
34
21.8
24
15.4
1
1
1
1
18
2
3
11.5
1.28
1.92 1.92
3
< LOQ 2
1
1
0
4
1
1
1
1
0.64
0
2.56
0.64
0.64
0.64
0.64
* (...truncated)